NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/16/2026
Back to search
Official data from USPTO
EPKIN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
EPKIN
ST13
US500000098814954Class
9, 42, 44
Filing
98814954
Registration
8300200
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
06/16/2026
Trademark type
Word
Nice classes
9, 42, 44
Filing date
10/22/2024
Registration date
06/16/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/16/2026
Last transaction
06/16/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
99
Owner location
Paris, FR
Examiner
LEE, OLIVIA SUNMIN
Law office
O10
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
EPKIN
Representatives
Andrew D. Bochner Bochner PLLC
Technical classification
Nice Classes
Class 9Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Downloadable artificial intelligence and machine learning software for developingrunning and analyzing algorithms that are able to learn to analyzeclassifytake actions in response to exposure to data; Downloadable artificial intelligence software for healthcare for developingrunning and analyzing algorithms that are able to learn to analyzeclassifytake actions in response to exposure to data; Downloadable computer software and programs using artificial intelligence for data and software processinggenerationunderstanding and analysis; downloadable computer programs and downloadable computer software for artificial intelligencecomputer software for developingrunning and analyzing algorithms that are able to learn to analyzeclassifytake actions in response to exposure to data; downloadable computer software for simulation environments for the purpose of testing artificial intelligence agentsalgorithms or programs; Downloadable computer software and programs for diagnosing health conditionprescribing treatments and writing prescriptionsdesigning clinical tests and forecasting clinical test resultssearching for clinical trial participantsanalysing medical imagesanalysing datadeveloping pharmaceuticals and chemical compounds
Class 42
Platform as a service (PAAS) featuring computer software platforms using artificial intelligence for activities relating to experimentationdesignresearch and development of therapeutic strategies and pharmaceutical specialtiesbiology and biochemistry; Research in the field of artificial intelligence technology; Technology consultation in the field of artificial intelligence; Software as a service (SaaS) featuring software for diagnosing health conditionprescribing treatments and writing prescriptionsdesigning clinical tests and forecasting clinical test resultssearching for clinical trial participantsanalysing medical imagesanalysing datadeveloping pharmaceuticals and chemical compounds; Scientific and technological servicesexperimentation being testingdesignresearch and development of therapeutic strategies and pharmaceutical specialtiesbiology and biochemistry in the field of oncology; Advisory services relating to scientific research; Scientific research; Engineering services; Technical consultancy services relating to computer programming; Research and development services in the field of engineering; Development of computer programs for others; Software design and development; Consultancy relating to research and development in the field of therapeutics solutions and pharmaceutical products; Scientific research in the nature of conducting clinical trials for others for pharmaceutical products; Scientific research in the nature of conducting clinical trials in the field of oncology; Scientific research relating to biology; Research and development in the field of biochemistry
Class 44
Medical services; Medical diagnostic services; Pharmaceutical advice; Providing medical information to medical professionals in the form of reports in the field of oncology; Medical services in the field of oncology
Publications
History of USPTO decisions and trademark events.
30 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/16/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/28/2026
PUBO
PUBLISHED FOR OPPOSITION
04/28/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/22/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/27/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/09/2026
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/09/2026
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/09/2026
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/09/2025
GNRT
NON-FINAL ACTION E-MAILED
12/09/2025
CNRT
NON-FINAL ACTION WRITTEN
12/09/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/29/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/29/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/29/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/18/2025
GNRT
NON-FINAL ACTION E-MAILED
08/18/2025
CNRT
NON-FINAL ACTION WRITTEN
08/18/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/11/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/11/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/11/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/12/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/12/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/12/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/12/2025
GNRT
NON-FINAL ACTION E-MAILED
05/12/2025
CNRT
NON-FINAL ACTION WRITTEN
05/12/2025
DOCK
ASSIGNED TO EXAMINER
04/24/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/23/2025
NWAP
NEW APPLICATION ENTERED
10/22/2024
Continuous trademark protection
Get notified about every new filing that threatens EPKIN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.